Threshold Pharmaceuticals

Key FDA Decisions and Trial Results Coming in the Next 2 Months
24/7 Wall St
Wed, 09/14/16 - 11:53 pm
FDA
clinical trials
Array Biopharma
binimetinib
Mast Therapeutics
Novavax
RSV F vaccine
Threshold Pharmaceuticals
tarloxotinib
Cerulean Pharma
Vertex Pharmaceuticals
Orkambi
Exelixis
cabozantinib
Cobimetinib
Medivation
Xtandi
Celldex
8 Major FDA Decisions and Trial Results to Watch for in September
24/7 Wall St
Sat, 09/3/16 - 12:17 pm
FDA
Achillion
odalasvir
AL-335
simeprevir
Amarin
Vascepa
Array Biopharma
binimetinib
Mast Therapeutics
vepoloxamer
Novavax
Threshold Pharmaceuticals
tarloxotinib
Threshold Pharmaceuticals posts 4Q profit
Yahoo/AP
Fri, 03/11/16 - 09:35 am
Threshold Pharmaceuticals
earnings
Merck KGaA, Threshold drug fails in late-stage cancer trials
Yahoo/Reuters
Mon, 12/7/15 - 10:21 am
Merck KGaA
Threshold Pharmaceuticals
evofosfamide
Beyond Chemotherapy: 4 Unique Ways Drug Developers Are Fighting Back Against Cancer
Motley Fool
Sun, 11/22/15 - 10:47 am
chemotherapy
cancer immunotherapies
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
targeted therapies
Pfizer
Xalkori
stem cells
OncoMed
tumor hypoxia
Threshold Pharmaceuticals
Threshold Pharmaceuticals posts 3Q loss
Yahoo/AP
Mon, 11/2/15 - 11:48 am
Threshold Pharmaceuticals
earnings
2 Biotech Stocks That Could Skyrocket In The Next 12 Months
Yahoo/Benzinga
Tue, 08/11/15 - 09:49 am
biotech
Biocryst
Threshold Pharmaceuticals
3 Biotech Stocks 50% (or More) Off Their 5-Year Highs That Could Double
Motley Fool
Thu, 07/16/15 - 02:27 pm
biotech
Xoma
Exelixis
Threshold Pharmaceuticals
Merck KGaA, Threshold win fast track for pancreatic cancer drug
Yahoo/Reuters
Tue, 05/12/15 - 10:19 am
Merck KGaA
Threshold Pharmaceuticals
pancreatic cancer
FDA
fast track
evofosfamide
19 Lesser-Known Biotech Stocks With Robust Drug Pipelines
Yahoo/Benzinga
Wed, 12/31/14 - 10:37 am
biotech
Threshold Pharmaceuticals
Acceleron
Spectrum Pharmaceuticals
Ultragenyx
Argos Therapeutics
OncoMed
Peregrine Pharmaceuticals
Incyte
Calithera
Array Biopharma
Theravance
Puma Biotechnology
CTI BioPharma
Orexigen
Enanta Pharmaceuticals
Sucampo
Exelixis
Cubist Pharmaceuticals
United Therapeutics
Encouraging Initial Data From Ongoing Phase 1/2 Trial of TH-302 Plus Bortezomib (Velcade(R)) Plus Dexamethasone ("TBorD") in Patients With Relapsed/Refractory Multiple Myeloma Presented at ASH Annual Meeting
Yahoo/MarketWired
Sun, 12/7/14 - 09:09 am
TH-302
Threshold Pharmaceuticals
Multiple Myeloma
Threshold Pharmaceuticals posts 3Q loss, results miss Wall Street forecasts
Yahoo/AP
Mon, 11/3/14 - 08:07 am
earnings
Threshold Pharmaceuticals
CTRC doctor wins $1.6 million FDA orphan grant to treat deadly brain tumors
phys.org
Sat, 10/4/14 - 10:12 am
TH-302
Threshold Pharmaceuticals
glioblastoma
brain cancer
Biotech Stock Mailbag: Threshold, Galena, CytRx
TheStreet.com
Fri, 08/22/14 - 12:04 pm
Threshold Pharmaceuticals
Galena Biopharma
CytRx
Threshold Initiates Phase 2 Clinical Trial In Advanced Non-Squamous Non-Small Cell Lung Cancer
Seeking Alpha
Tue, 07/8/14 - 07:52 am
Threshold Pharmaceuticals
non-small cell lung cancer
TH-302
Three Biotechs That Could Double
Yahoo/Street Authority
Thu, 06/5/14 - 09:29 am
Verastem
Versartis
Threshold Pharmaceuticals
Threshold Pharmaceuticals Announces Data From Two Ongoing Phase 1/2 Trials of TH-302 at the 2013 ASCO Annual Meeting
Yahoo/MarketWire
Sun, 06/2/13 - 11:39 am
Threshold Pharmaceuticals
TH-302
Multiple Myeloma
gastrointestinal stromal tumors
renal cell carcinoma
kidney cancer
3 Biotechs And The Feuerstein-Ratain Rule
Seeking Alpha
Tue, 04/9/13 - 10:44 am
Ziopharm
Threshold Pharmaceuticals
Celsion
A Look at Three Biotech Movers
Motley Fool
Sat, 01/26/13 - 11:43 am
Sarepta Therapeutics
Celsion
Threshold Pharmaceuticals
3 Biotech Stocks Surging Higher With Volume
Seeking Alpha
Fri, 01/25/13 - 08:15 am
Allergan
Keryx
MAP Pharmaceuticals
Threshold Pharmaceuticals

Pages